Nearly all IFS tumors harbor a neurotrophic tyrosine receptor kinase (NTRK) fusion, with 70% of IFS cases containing the ETS Variant Transcription Factor 6 (ETV6)-NTRK3 gene rearrangement (Knezevich et al., 1998). Here, ETV6 is linked to congenital fibrosarcoma.